Journal
CHEST
Volume 140, Issue 1, Pages 230-238Publisher
AMER COLL CHEST PHYSICIANS
DOI: 10.1378/chest.11-0610
Keywords
-
Categories
Funding
- National Institutes of Health (NIH)
- Society of Critical Care Medicine
- American Thoracic Society
- Actelion Pharmaceuticals Ltd
- Bayer Corporation
- Genzyme Corporation
- Gilead
- Pfizer Inc
- Respironics Inc
- United Therapeutics Corporation
- Pulmonary Association
- Blackwell Publishers
- UpToDate Inc
- Humana Publishers
- New England Institute
- National Association for Medical Direction of Respiratory Care
- Eisai, Inc
- Eli Lilly and Company
- Journal of the American Medical Association
- Wyeth
- Novartis Pharmaceuticals Corporation
- bioMerieux SA
- Roche
- CareFusion Corporation
- Robert Wood Johnson Foundation
- Advanced Lifeline Services, Inc
- Siemens Corporation
- Byk-Gulden GmbH
- AstraZeneca
- Faron Pharmaceuticals Ltd
- Cerus Corporation
- DHD
- Hospira, Inc
- Cerner Corporation
- Kinetic Concepts Inc
- American Association for Respiratory Care
- Alberta Heritage Foundation for Medical Research
- McKesson Corp
- Rx Foundation
- American Society of Health Systems Pharmacists Foundation
- Shared Health (Chattanooga, Tennessee)
- Institute for Safe Medication Practice
- Canadian Health Services Research Foundation
- Alberta Innovates-Health Solution
- Canadian Institutes for Health Research
- National Institute for Nursing Research (NIH)
- Heart and Stroke Foundation of Canada
- Ontario Ministry of Health and Long Term Care
- Baxter Healthcare
- American College of Chest Physicians
- US Agency for Healthcare Research and Quality [R13HS19946]
Ask authors/readers for more resources
ICU telemedicine uses audiovisual conferencing technology to provide critical care from a remote location. Research is needed to best define the optimal use of ICU telemedicine, but efforts are hindered by methodological challenges and the lack of an organized delivery approach. We convened an interdisciplinary working group to develop a research agenda in ICU telemedicine, addressing both methodological and knowledge gaps in the field. To best inform clinical decision-making and health policy, future research should be organized around a conceptual framework that enables consistent descriptions of both the study setting and the telemedicine intervention. The framework should include standardized methods for assessing the preimplementation ICU environment and describing the telemedicine program. This framework will facilitate comparisons across studies and improve generalizability by permitting context-specific interpretation. Research based on this framework should consider the multidisciplinary nature of ICU care and describe the specific program goals. Key topic areas to be addressed include the effect of ICU telemedicine on the structure, process, and outcome of critical care delivery. Ideally, future research should attempt to address causation instead of simply associations and elucidate the mechanism of action in order to determine exactly how ICU telemedicine achieves its effects. ICU telemedicine has significant potential to improve critical care delivery, but high-quality research is needed to best inform its use. We propose an agenda to advance the science of ICU telemedicine and generate research with the greatest potential to improve patient care. CHEST 2011; 140(1):230-238
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available